The Ministry of Health in the Kingdom of Saudi Arabia to recommend the implementation of the Biology Transfusion Solution

 This information is communicated to you confidentially; it will be the subject of a joint Press Release with the Ministry of Health, including in particular their testimony. 

 Following a thorough evaluation, the Ministry of Health (MOH) in the Kingdom of Saudi Arabia has issued a positive recommendation concerning the implementation of the Biolog Transfusion Solution in all regions of the country. 

Led in the Riyadh region, this several months evaluation was implemented with the support of biolog-id’s local partner – Dar Al Najat – at the regional blood bank and the reputed King Salman Hospital. The main goal was to evaluate how our RFID solution can impact three application areas: global real time inventory visibility and management across several centers, guarantee blood products integrity during transportation and secure the administration of the right product to the right patient. 

With approximately 1,500 blood bags under evaluation, the MOH underlines that biolog-id solution enables real time and efficient stock management avoiding any waste, while improving working conditions of the healthcare professionals. At the same time, the institution concludes that this cutting-edge technology guarantees transport conditions and duration controls at reception, securing accordingly the quality of each unit. Concerning bedside administration, the evaluation states that this solution provides a reliable control of patient/product match. 

This evaluation was carried out as part of the government strategy aiming to implement a system that provides complete traceability of each unit from vein-to-vein covering all blood banks in the country. After this very favorable evaluation report, the process towards establishing a commercial contract has started for the deployment of our solution nationwide – representing 24 regional blood banks supporting more than 200 hospitals. 

About biolog-id 

Biolog-id develops and implements innovative solutions, that digitally transform routine processes into actionable data supporting better operational and strategic decisions for sensitive therapeutic products. 

The information generated by biolog-id solutions is available to Healthcare Professionals at any time, enhancing their processes efficiency, work conditions and ultimately the safety of the therapeutics administered to patients. 

Biolog-id’s patented platform is utilized in North America, Europe, Middle East, India, and Asia Pacific. Biolog-id is owned by its founder, managers, and Xerys Invest. Xerys Invest is a French investment company primarily positioned on trending sectors that include healthcare & Life Sciences, renewable energy/GreenTech and new digital technologies. 

Company URL: 




7 rue d’Aguesseau

75008 Paris - France

+33 (0)1 82 52 12 25